Legend Biotech annual return on equity
2019
2020
2021
2022
2023
2024
2025
Legend Biotech Return on Equity (ROE) Growth & History (LEGN)
Legend Biotech's return on equity was −29.06% for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −29.06% | −13.61 pp |
| 2024 | 2024-12-31 | −15.45% | +36.50 pp |
| 2023 | 2023-12-31 | −51.94% | +7.17 pp |
| 2022 | 2022-12-31 | −59.11% | +0.08 pp |
| 2021 | 2021-12-31 | −59.19% | +52.99 pp |
| 2020 | 2020-12-31 | −112.18% | +44.06 pp |
| 2019 | 2019-12-31 | −156.24% | — |
Legend Biotech quarterly return on equity
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.02% | +15.23 pp |
| Q1 2026 | 2026-03-31 | −5.51% | +4.29 pp |
| Q4 2025 | 2025-12-31 | −3.06% | −5.50 pp |
| Q3 2025 | 2025-09-30 | −3.88% | +7.14 pp |
| Q2 2025 | 2025-06-30 | −12.21% | −10.65 pp |
| Q1 2025 | 2025-03-31 | −9.81% | −4.85 pp |
| Q4 2024 | 2024-12-31 | 2.44% | +13.62 pp |
| Q3 2024 | 2024-09-30 | −11.02% | −6.49 pp |
| Q2 2024 | 2024-06-30 | −1.57% | +16.95 pp |
| Q1 2024 | 2024-03-31 | −4.95% | — |
| Q4 2023 | 2023-12-31 | −11.18% | — |
| Q3 2023 | 2023-09-30 | −4.53% | — |
| Q2 2023 | 2023-06-30 | −18.51% | — |
Legend Biotech return on equity trends
Over the last five fiscal years, Legend Biotech's return on equity increased from −112.18% to −29.06%, a change of +83.12 percentage points. The latest reported quarter, Q2 2026, shows 3.02%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗